Literature DB >> 1532256

Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

G P Gasic1, C P Arenas, T B Gasic, G J Gasic.   

Abstract

Smooth muscle cells (SMCs) in the rat carotid artery leave the quiescent state and proliferate after balloon catheter injury. The precise signals responsible for this SMC mitogenesis need to be elucidated. Although platelet-derived growth factor (PDGF), a potent SMC mitogen, is released from activated platelets, damaged endothelium, and macrophages, it cannot be solely responsible for this proliferation. In search of other SMC growth factors, we have examined several proteins of the coagulation cascade. At nanomolar concentrations, factors X, Xa, and protein S promote cultured rat aortic SMC mitosis. In contrast, factor IX is only weakly mitogenic, whereas factor VII and protein C fail to stimulate SMC division. Protein S, the most mitogenic of these coagulation cascade factors, stimulates DNA synthesis in cultured SMCs with a time course similar to that of PDGF-AA and without the delay observed for transforming growth factor beta. Antistasin and tick anticoagulant peptide, two specific factor Xa inhibitors, inhibit SMC mitogenesis due to Xa and protein S. Coagulation factors that possess mitogenic activity may contribute to intimal SMC proliferation after vascular injury as a result of angioplasty or vascular compromise during atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532256      PMCID: PMC48648          DOI: 10.1073/pnas.89.6.2317

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  The regulation of natural anticoagulant pathways.

Authors:  C T Esmon
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

2.  A biologically plausible model of thickening of arterial intima under shear.

Authors:  M H Friedman
Journal:  Arteriosclerosis       Date:  1989 Jul-Aug

3.  Primary structure of bovine vitamin K-dependent protein S.

Authors:  B Dahlbäck; A Lundwall; J Stenflo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 4.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

5.  Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted.

Authors:  I Vlodavsky; R Fridman; R Sullivan; J Sasse; M Klagsbrun
Journal:  J Cell Physiol       Date:  1987-06       Impact factor: 6.384

Review 6.  The molecular basis of blood coagulation.

Authors:  B Furie; B C Furie
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

Review 7.  Restenosis following coronary angioplasty.

Authors:  C Fanelli; R Aronoff
Journal:  Am Heart J       Date:  1990-02       Impact factor: 4.749

8.  Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S.

Authors:  B Dahlbäck
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

9.  Growth inhibition by protein kinase C late in mitogenesis.

Authors:  C L Huang; H E Ives
Journal:  Nature       Date:  1987 Oct 29-Nov 4       Impact factor: 49.962

Review 10.  Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.

Authors:  M W Liu; G S Roubin; S B King
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

View more
  32 in total

Review 1.  Protease activated receptor 2 and the cardiovascular system.

Authors:  Carla Cicala
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 2.  Biology of the TAM receptors.

Authors:  Greg Lemke
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

3.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

4.  A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.

Authors:  Yoshiyuki Morishima; Yuko Honda
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

5.  A novel role for vitamin K1 in a tyrosine phosphorylation cascade during chick embryogenesis.

Authors:  S P Saxena; T Fan; M Li; E D Israels; L G Israels
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

6.  Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo.

Authors:  G Cirino; C Cicala; M Bucci; L Sorrentino; G Ambrosini; G DeDominicis; D C Altieri
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

7.  Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.

Authors:  Donghui Zhu; Yaoming Wang; Itender Singh; Robert D Bell; Rashid Deane; Zhihui Zhong; Abhay Sagare; Ethan A Winkler; Berislav V Zlokovic
Journal:  Blood       Date:  2010-03-26       Impact factor: 22.113

Review 8.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

9.  Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat.

Authors:  F N Ko; Y C Yang; S C Huang; J T Ou
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

10.  The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade.

Authors:  G Manfioletti; C Brancolini; G Avanzi; C Schneider
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.